|
rdf:type |
|
|
lifeskim:mentions |
umls-concept:C0013081,
umls-concept:C0019163,
umls-concept:C0032854,
umls-concept:C0033325,
umls-concept:C0332281,
umls-concept:C0439849,
umls-concept:C0445223,
umls-concept:C1552599,
umls-concept:C1561558,
umls-concept:C1704787,
umls-concept:C1826565,
umls-concept:C2239176
|
|
pubmed:issue |
5
|
|
pubmed:dateCreated |
2010-10-4
|
|
pubmed:abstractText |
Phosphatidylethanolamine-binding protein 1 (PEBP1, also RKIP) plays a pivotal role in cancer by regulating multiple cellular signaling processes and suppressing metastasis in animal models. We examined whether PEBP1 expression in hepatocellular carcinoma (HCC) correlated with the risk of recurrence and survival after resection.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Nov
|
|
pubmed:issn |
0168-8278
|
|
pubmed:author |
pubmed-author:CaiMing-YanMY,
pubmed-author:DaiChen-XinCX,
pubmed-author:GaoQiangQ,
pubmed-author:JuMin-JieMJ,
pubmed-author:LeeJ SJS,
pubmed-author:LiYi-WeiYW,
pubmed-author:QiuShuang-JianSJ,
pubmed-author:XuYong-FengYF,
pubmed-author:YiYongY,
pubmed-author:ZhangBo-HengBH,
pubmed-author:ZhouJianJ
|
|
pubmed:copyrightInfo |
Copyright © 2010 European Association for the Study of the Liver. Published by Elsevier B.V. All rights reserved.
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
53
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
872-9
|
|
pubmed:meshHeading |
pubmed-meshheading:20739083-Adult,
pubmed-meshheading:20739083-Aged,
pubmed-meshheading:20739083-Carcinoma, Hepatocellular,
pubmed-meshheading:20739083-Cell Line, Tumor,
pubmed-meshheading:20739083-Down-Regulation,
pubmed-meshheading:20739083-Extracellular Signal-Regulated MAP Kinases,
pubmed-meshheading:20739083-Female,
pubmed-meshheading:20739083-Hepatitis B,
pubmed-meshheading:20739083-Humans,
pubmed-meshheading:20739083-Liver Neoplasms,
pubmed-meshheading:20739083-MAP Kinase Signaling System,
pubmed-meshheading:20739083-Male,
pubmed-meshheading:20739083-Middle Aged,
pubmed-meshheading:20739083-Neoplasm Recurrence, Local,
pubmed-meshheading:20739083-Phosphatidylethanolamine Binding Protein,
pubmed-meshheading:20739083-Prognosis
|
|
pubmed:year |
2010
|
|
pubmed:articleTitle |
PEBP1 downregulation is associated to poor prognosis in HCC related to hepatitis B infection.
|
|
pubmed:affiliation |
Liver Cancer Institute, Zhong Shan Hospital, Fudan University, Shanghai, People's Republic of China.
|
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|
